NorthWest Biotherapeutics Inc (NWBO)

[GoodGuyBill]

You are missing the point, so let me repeat, by adding NWBO's DCVax-L to the HCD list,

NHS has formally validated DCVax-L’s safety, efficacy, and therapeutic value in treating newly diagnosed and recurrent brain cancers, and possibly even all tumor-based cancers, while also recognizing that this approval, at the moment, comes with case-by-case limitations under IFR.

Regardless of how one chooses to phrase it, one fact remains undeniable, unassailable, and beyond reproach—by adding DCVax-L to the HCD list, NHS England has cemented its legitimacy as a valuable cancer treatment.

As for the persistent naysayers—those who have knowingly or unknowingly spread FUD about trial data, accused NWBO of cherry-picking results, or claimed the trial was a failure [or that DCVax-L would NEVER get approval]—their arguments have now been effectively discredited. The evidence speaks for itself, and their narrative no longer holds weight.

FUDsters can no longer say DCVax-L doesn't work, is not efficacious or is no different than grapefruit juice (does anyone remember that one, lol?)!

In regard to your calculations and main point, I call utter bullshit! Here's why?

NHS England has recently increased funding for cancer treatment through several initiatives.

The Cancer Drugs Fund (CDF) has provided early access to innovative treatments for nearly 100,000 patients, allowing faster availability of promising therapies.

The UK government has allocated £2 billion for cancer diagnosis technology, aiming to reduce delays and improve survival rates.

The Autumn Budget 2024 protected £20.4 billion for research and development, including funding for cancer research and clinical trials.

These investments suggest a strong commitment to expanding cancer treatment options, which could influence future funding decisions for therapies like DCVax-L.

Also, have you ever considered that the IFR funding was designed to get the treatment immediately to patients until NICE submits its recommendation? Furthermore, with NHS's explicit validation of DCVax-L's safety, efficacy and value to treating cancer, doesn't that open access to self-funded individuals and private health organization to provide DCVax-L. If this is the case, could self-funding foreign patients do this too?

At least, by trying to trivialize the funding NWBO will receive via DCVax-L IFR, you acknowledge (indirectly) that the NHS is allowing patients access to DCVax-L. Of course, you can't refute it so, instead, you claim NWBO won't make any $$$. You know that is bullshit. We will all get paid.